Hultcrantz, M., Hassoun, H., Korde, N., Tan, C., Giralt, S., Lesokhin, A., Maclachlan, K., Patel, D., Shah, U., Rajeeve, S., Hashmi, H., Derkach, A., Firestone, R., Tran, L., Hyland, M., Murata, K., Herrera, K., Perica, K., Usmani, S., Mailankody, S. (2025). Belantamab mafodotin, nirogacestat, and pomalidomide in patients with relapsed/refractory multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-4060